Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells

Despite the development of specific therapies against severe acute respiratory coronavirus 2 (SARS-CoV-2), the continuous investigation of the mechanism of action of clinically approved drugs could provide new information on the druggable steps of virus–host interaction. For example, chloroquine (CQ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacramento, Carolina Q., Fintelman-Rodrigues, Natalia, Dias, Suelen S. G., Temerozo, Jairo R., Da Silva, Aline de Paula D., da Silva, Carine S., Blanco, Camilla, Ferreira, André C., Mattos, Mayara, Soares, Vinicius C., Pereira-Dutra, Filipe, Miranda, Milene Dias, Barreto-Vieira, Debora F., da Silva, Marcos Alexandre N., Santos, Suzana S., Torres, Mateo, Chaves, Otávio Augusto, Rajoli, Rajith K. R., Paccanaro, Alberto, Owen, Andrew, Bou-Habib, Dumith Chequer, Bozza, Patrícia T., Souza, Thiago Moreno L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874959/
https://www.ncbi.nlm.nih.gov/pubmed/35215969
http://dx.doi.org/10.3390/v14020374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874959/
https://www.ncbi.nlm.nih.gov/pubmed/35215969
http://dx.doi.org/10.3390/v14020374

Ejemplares similares